Understanding Breast Cancer Risk and Screening in Transgender Persons through a Pilot Breast Cancer Screening Program
通过乳腺癌筛查试点计划了解跨性别者的乳腺癌风险和筛查
基本信息
- 批准号:10738974
- 负责人:
- 金额:$ 21.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-20 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAgeAmericanAnxietyAppearanceAwardBiopsyBirthBreastBreast Cancer DetectionBreast Cancer Risk FactorCallbackCaringChest MassClinicCohort StudiesCollaborationsCommunitiesComplementConsensusCoupledDataDatabasesDecision MakingDedicationsDetectionDevelopmentElectronicsEquityEstrogensExposure toFaceFacultyFocus GroupsFoundationsFundingFutureGenderGender IdentityGoalsHealthHealth PersonnelHealthcare SystemsHormonalImageIncidenceIndividualInferiorInstitutionInterviewKnowledgeLesbian Gay Bisexual Transgender QueerLesionLiteratureMalignant NeoplasmsMammary Gland ParenchymaMammary UltrasonographyMammographic screeningMammographyMass in breastMediatingMedicalMental HealthMentorsMentorshipMethodsMinority GroupsModelingOperative Surgical ProceduresParticipantPathologyPerceptionPersonsPopulationPractice GuidelinesProcessProspective cohortProviderQualitative MethodsRadiology SpecialtyRegistriesReportingResearchResearch DesignResearch ProposalsRiskRisk FactorsRoleScientistScreening for cancerSensitivity and SpecificityStage at DiagnosisStigmatizationSuggestionSurgeonSurveysTestosteroneTimeTissuesTrainingTraining and EducationUnited States National Institutes of HealthWomanWorkassigned female at birthassigned male at birthbreast imagingcancer carecancer health disparitycareercis-femalecis-malecisgendercohortdesignevidence baseexperiencegender affirming hormone therapyhealth beliefimprovedinnovationinsightlifetime riskmalignant breast neoplasmmennovelparticipant interviewpreventprocess improvementprogramsprospectivepsychologicpsychosocialrecruitroutine screeningscreeningscreening guidelinesscreening programsexsex assigned at birthskillssocialsystem-level barrierstransgendertransgender mentransgender women
项目摘要
PROJECT SUMMARY/ABSTRACT
In the U.S., an estimated 1.4 million people identify as transgender (TG), defined as a person whose gender is
different than their sex assigned at birth, and are a designated minority population by the NIH (NOT-MD-19-001).
Many TG persons take gender-affirming hormone therapy, usually estrogen or testosterone based, to alter their
physical appearance and improve their psychological health. Lifetime exposure to estrogen is a well-established
risk factor for breast cancer (BC). Despite a growing TG population, the risk of developing BC in TG persons is
unclear and there is no consensus on how to ideally screen this undeserved population for BC. These knowledge
gaps prevent informed decision-making among healthcare providers and TG persons, likely contributing to the
cancer disparities observed in the TG community. The overarching goal of my research agenda is to develop
evidence-based TG BC screening guidelines. The proposed K08 will begin to fill critical knowledge gaps. In
collaboration with our LGBTQ+ Inclusion Health Clinic, we will establish a pilot BC screening program and utilize
a mixed methods approach to explore BC risk and screening in this population. These data will provide the
necessary foundation to develop a multi-institutional longitudinal TG BC screening cohort study which will inform
the development of BC screening guidelines and best practices for BC screening within the TG community. The
foundational K08 work will be accomplished through three specific aims: 1) determine the callback and biopsy
rates of TG persons after screening mammography and automated breast ultrasonography, 2) assess
perceptions towards BC risk, screening, and the screening experience of TG individuals through surveys and
interviews, and 3) identify individual and systems-level barriers to BC screening for TG persons and methods to
optimize the screening process through interviews and focus groups. These findings will provide the first-ever
prospective scientific data on screening mammography and automated breast ultrasonography lesion detection
in TG persons. The qualitative data from Aims 2 and 3 will identify individual and systems-level barriers to
screening and opportunities to improve the screening process and experience. The research proposal is
complemented by a comprehensive and distinctive training plan focused on mixed methods and survey research,
gender studies, database development, and cohort recruitment and retention. In combination with my diverse
and collaborative mentorship team, this study and training plan is designed to optimize my seamless transition
to becoming an independently funded surgeon–scientist and my efforts to mitigate BC disparities in TG persons
through a 3-step process. The novel pilot BC screening study (Step 1) will provide the necessary preliminary
data and experience to submit an R01 application to develop a multi-institutional longitudinal TG BC screening
program (Step 2) which will definitively establish the lifetime risk and incidence of BC to inform the development
of evidence-based BC screening guidelines for TG persons and best practice guidelines (Step 3).
项目概要/摘要
在美国,估计有 140 万人被认定为跨性别者 (TG),跨性别者的定义是性别为
与出生时指定的性别不同,并且是 NIH 指定的少数群体 (NOT-MD-19-001)。
许多 TG 患者接受性别肯定激素治疗,通常是基于雌激素或睾酮的治疗,以改变他们的性别
终生接触雌激素已是公认的。
乳腺癌 (BC) 的危险因素 尽管 TG 人群不断增长,但 TG 人群患 BC 的风险仍然很高。
对于如何理想地筛查这些不合格人群的 BC,目前尚不清楚,也没有达成共识。
防止医疗保健提供者和 TG 人员之间的知情决策差距,这可能有助于
我的研究议程的首要目标是发展 TG 群体中观察到的癌症差异。
拟议的 K08 将开始填补关键的知识空白。
与我们的 LGBTQ+ 包容性健康诊所合作,我们将建立试点 BC 筛查计划并利用
这些数据将提供探索 BC 风险和筛查的混合方法。
开展多机构纵向 TG BC 筛查队列研究的必要基础,该研究将提供信息
制定 TG 社区内 BC 筛查指南和 BC 筛查最佳实践。
K08 的基础工作将通过三个具体目标来完成:1)确定回调和活检
筛查乳房 X 光检查和自动乳腺超声后 TG 人群的比率,2)评估
通过调查和 TG 个人的看法 BC 风险、筛查和筛查经验
访谈,以及 3) 确定对 TG 人员进行 BC 筛查的个人和系统层面的障碍以及方法
通过访谈和焦点小组优化筛选过程这些发现将提供有史以来的第一次。
关于筛查乳房X光检查和自动乳房超声检查病变检测的前瞻性科学数据
目标 2 和 3 的定性数据将确定个人和系统层面的障碍。
筛选以及改进筛选过程和体验的机会。
辅以全面且独特的培训计划,重点关注混合方法和调查研究,
性别研究、数据库开发以及队列招募和保留与我的多元化相结合。
和协作导师团队,这个学习和培训计划旨在优化我的无缝过渡
成为一名独立资助的外科医生兼科学家以及我为减少 TG 人群的 BC 差异所做的努力
通过三步流程,新颖的 BC 筛选研究(步骤 1)将提供必要的初步结果。
提交 R01 申请以开发多机构纵向 TG BC 筛查的数据和经验
计划(步骤 2)将明确确定 BC 的终生风险和发病率,为发展提供信息
针对 TG 人员的基于证据的 BC 筛查指南和最佳实践指南(步骤 3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chandler Scott Cortina其他文献
Chandler Scott Cortina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The neural underpinnings of speech and nonspeech auditory processing in autism: Implications for language
自闭症患者言语和非言语听觉处理的神经基础:对语言的影响
- 批准号:
10827051 - 财政年份:2024
- 资助金额:
$ 21.03万 - 项目类别:
Computational and neural signatures of interoceptive learning in anorexia nervosa
神经性厌食症内感受学习的计算和神经特征
- 批准号:
10824044 - 财政年份:2024
- 资助金额:
$ 21.03万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 21.03万 - 项目类别:
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 21.03万 - 项目类别: